NB
HOLX

Norinchukin Bank’s Hologic HOLX Stock Holding History

Norinchukin Bank’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,804
Closed -$1.04M – 572
2026
Q1 		$1.04M Buy
13,804
+91
+0.7% +$6.84K 0.01% 432
2025
Q4 		$1.02M Buy
13,713
+935
+7% +$68.3K 0.01% 441
2025
Q3 		$862K Buy
12,778
+401
+3% +$26.6K 0.01% 446
2025
Q2 		$806K Buy
12,377
+209
+2% +$12.5K 0.01% 449
2025
Q1 		$752K Buy
12,168
+1,408
+13% +$93.3K 0.01% 439
2024
Q4 		$776K Buy
10,760
+1,000
+10% +$78.1K 0.02% 408
2024
Q3 		$795K Buy
9,760
+1,408
+17% +$113K 0.02% 389
2024
Q2 		$620K Buy
8,352
+189
+2% +$14.2K 0.02% 388
2024
Q1 		$636K Sell
8,163
-447
-5% -$33.3K 0.02% 389
2023
Q4 		$615K Sell
8,610
-850
-9% -$59.2K 0.01% 390
2023
Q3 		$657K Sell
9,460
-10,694
-53% -$808K 0.02% 367
2023
Q2 		$1.63M Buy
20,154
+4,317
+27% +$353K 0.03% 338
2023
Q1 		$1.28M Buy
15,837
+343
+2% +$27.6K 0.03% 328
2022
Q4 		$1.16M Sell
15,494
-3,661
-19% -$261K 0.03% 331
2022
Q3 		$1.24M Buy
19,155
+2,141
+13% +$148K 0.03% 335
2022
Q2 		$1.18M Sell
17,014
-6,179
-27% -$459K 0.02% 337
2022
Q1 		$1.78M Buy
23,193
+1,394
+6% +$100K 0.02% 342
2021
Q4 		$1.67M Sell
21,799
-139
-0.6% -$10.2K 0.02% 350
2021
Q3 		$1.62M Buy
21,938
+735
+3% +$55.1K 0.02% 343
2021
Q2 		$1.42M Sell
21,203
-193
-0.9% -$12.9K 0.02% 366
2021
Q1 		$1.59M Buy
21,396
+361
+2% +$27.4K 0.02% 321
2020
Q4 		$1.53M Sell
21,035
-690
-3% -$48.7K 0.02% 299
2020
Q3 		$1.44M Buy
21,725
+342
+2% +$21.6K 0.02% 290
2020
Q2 		$1.22M Sell
21,383
-1,057
-5% -$51.9K 0.02% 312
2020
Q1 		$788K Sell
22,440
-13,062
-37% -$622K 0.02% 350
2019
Q4 		$1.85M Sell
35,502
-3,203
-8% -$159K 0.02% 346
2019
Q3 		$1.95M Buy
38,705
+951
+3% +$46.8K 0.03% 341
2019
Q2 		$1.81M Sell
37,754
-13,077
-26% -$605K 0.03% 353
2019
Q1 		$2.46M Buy
50,831
+1,480
+3% +$66.7K 0.03% 339
2018
Q4 		$2.03M Buy
49,351
+14,360
+41% +$589K 0.03% 349
2018
Q3 		$1.43M Buy
34,991
+4,058
+13% +$164K 0.02% 395
2018
Q2 		$1.23M Buy
30,933
+5,595
+22% +$215K 0.02% 394
2018
Q1 		$947K Buy
25,338
+3,296
+15% +$133K 0.02% 412
2017
Q4 		$942K Buy
22,042
+1,166
+6% +$46.5K 0.02% 405
2017
Q3 		$766K Buy
20,876
+1,445
+7% +$58.3K 0.01% 427
2017
Q2 		$882K Buy
19,431
+1,282
+7% +$56.6K 0.02% 386
2017
Q1 		$772K Buy
18,149
+1,271
+8% +$51.8K 0.02% 398
2016
Q4 		$677K Buy
16,878
+2,026
+14% +$78.2K 0.02% 399
2016
Q3 		$577K Buy
14,852
+2,128
+17% +$80.3K 0.01% 418
2016
Q2 		$440K Buy
12,724
+53
+0.4% +$1.83K 0.01% 445
2016
Q1 		$437K Buy
+12,671
New +$442K 0.01% 447

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Norinchukin Bank's HOLX Position: Q2 2026 in Review

Norinchukin Bank sold out of Hologic (HOLX) in Q2 2026, closing a stake of 13,804 shares — an estimated $1.04M sold.

Norinchukin Bank first reported a position in HOLX in Q1 2016 and held it in 41 quarters. The position peaked at $2.46M in Q1 2019. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Norinchukin Bank reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Norinchukin Bank sold 13,804 Hologic shares in Q2 2026, an estimated $1.04M.
  • Norinchukin Bank first reported a position in Hologic in Q1 2016 and held it in 41 quarters.
  • Norinchukin Bank's Hologic position peaked at $2.46M in Q1 2019.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.